HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
- PMID: 33272901
- PMCID: PMC8164644
- DOI: 10.1016/j.smim.2020.101438
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
Abstract
Antiretroviral therapy controls HIV replication but does not eliminate the virus from the infected host. The persistence of a small pool of cells harboring integrated and replication-competent HIV genomes impedes viral eradication efforts. The HIV reservoir was originally described as a relatively homogeneous pool of resting memory CD4+ T cells. Over the past 20 years, the identification of multiple cellular subsets of CD4+ T cells endowed with distinct biological properties shed new lights on the heterogeneity of HIV reservoirs. It is now clear that HIV persists in a large variety of CD4+ T cells, which contribute to HIV persistence through different mechanisms. In this review, we summarize recent findings indicating that specific biological features of well-characterized subsets of CD4+ T cells individually contribute to the persistence of HIV. These include an increased sensitivity to HIV infection, specific tissue locations, enhanced survival and heightened capacity to proliferate. We also discuss the relative abilities of these cellular reservoirs to contribute to viral rebound upon ART interruption. Together, these findings reveal that the HIV reservoir is not homogeneous and should be viewed as a mosaic of multiple cell types that all contribute to HIV persistence through different mechanisms.
Keywords: CD4+ T cells; Central memory cells; HIV reservoir; Latency; Tfh; Tissues.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures
Similar articles
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs.J Virol. 2021 Jul 12;95(15):e0242520. doi: 10.1128/JVI.02425-20. Epub 2021 Jul 12. J Virol. 2021. PMID: 33980597 Free PMC article.
-
Infectious Virus Persists in CD4+ T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.J Virol. 2019 Jul 17;93(15):e00065-19. doi: 10.1128/JVI.00065-19. Print 2019 Aug 1. J Virol. 2019. PMID: 31118264 Free PMC article.
-
The multifaceted nature of HIV latency.J Clin Invest. 2020 Jul 1;130(7):3381-3390. doi: 10.1172/JCI136227. J Clin Invest. 2020. PMID: 32609095 Free PMC article. Review.
-
The challenge of viral reservoirs in HIV-1 infection.Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.
Cited by
-
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption.Nat Immunol. 2024 Oct;25(10):1900-1912. doi: 10.1038/s41590-024-01952-4. Epub 2024 Sep 12. Nat Immunol. 2024. PMID: 39266691 Free PMC article.
-
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?Viruses. 2024 Feb 1;16(2):229. doi: 10.3390/v16020229. Viruses. 2024. PMID: 38400005 Free PMC article. Review.
-
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment.Front Immunol. 2022 Apr 26;13:847816. doi: 10.3389/fimmu.2022.847816. eCollection 2022. Front Immunol. 2022. PMID: 35558085 Free PMC article.
-
Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART.Pathog Immun. 2021 Oct 1;6(2):60-89. doi: 10.20411/pai.v6i2.447. eCollection 2021. Pathog Immun. 2021. PMID: 34988339 Free PMC article.
-
Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection.Viruses. 2022 Oct 9;14(10):2218. doi: 10.3390/v14102218. Viruses. 2022. PMID: 36298774 Free PMC article.
References
-
- Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF, In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency, Nat Med 1(12) (1995) 1284–90. - PubMed
-
- Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF, Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection, Nature 387(6629) (1997) 183–8. - PubMed
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF, Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science 278(5341) (1997) 1295–300. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous